|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Institute of Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany;
Institute of General Practice, Hannover Medical School, Hannover, Germany;
Immunology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, Australia;
Department of Internal Medicine I, University Hospital of Regensburg, Regensburg, Germany;
¶ Probiodrug, Halle (Saale), Germany;
|| Clinic for Cardiology and Angiology, Hannover Medical School, Hannover, Germany;
# Clinic for Immunology and Rheumatology, Hannover Medical School, Hannover, Germany; and
** Experimental Therapy, Franz-Pentzoldt Center, Friedrich-Alexander University, Erlangen, Germany
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A number of studies have indicated implications of the maternal-neonatal neuroimmune interface for inflammatory and stress-related diseases (4, 5). Rodent models investigating the importance of maternal factors in the development of endocrine and immune regulation have largely used prolonged maternal separation (MS)3/deprivation or short separation (handling stimulation (HA)) paradigms (5). For instance, in experimental allergic encephalomyelitis—an animal model for multiple sclerosis—the clinical signs of the disease increased after MS (6). However, postnatal HA did not alter the susceptibility to another autoimmune condition, adjuvant-induced arthritis (7). Regarding the immense increase in atopic diseases such as allergic asthma (8), it would be of great value to know whether immunobiological evidence for specific adverse experiences very early in life can be elucidated as a pathogenetic factor for the development and course of asthmatic airway disease.
In the current study, we used established rat models integrating two opposing experimental paradigms of postnatal stress (HA, MS), and collected behavioral, neuroendocrinological, and immunological readouts throughout later adult life of the individuals. In the rat asthma model, T cells are known to play a major role in the promotion of airway eosinophilia as well as an isotype switching to IgE via the secretion of several type 2 cytokines, such as IL-4, IL-5, IL-13 (9). In addition, CD26 (dipeptidyl peptidase 4) is, among several other functions, an activation marker of T lymphocytes. In a previous study, we were able to identify CD26 in various rat strains including Fischer 344 (F344) rats as a necessary prerequisite for the induction of allergic airway inflammation (10). This "orchestra" of responsible factors leads to airway narrowing resulting in the typical clinical pattern of asthma symptoms. Our aim was to find out whether postnatal exposure to different stressors, representing experimental paradigms for specific nongenetic factors acting early in life and being different from antigenic hygienic factors, can modulate asthmatic airway inflammation in adult genetically identical inbred rats. Such "artificial life histories" in rodents provide a novel, well-controlled approach to a more comprehensive understanding of the potential role of noninfectious and nongenetic factors that modulate disease susceptibility of the individual and which are extremely difficult to detect in epidemiological studies in humans. The hypothesis is that these postnatal stressors induce long-lasting changes in the adaptive capacity of the individual neuroendocrinoimmune network at various levels.
| Materials and Methods |
|---|
|
|
|---|
Offspring of 18 (experiment 1) and 14 (experiment 2) time-mated primaparous Fischer F344 females were born and kept in a colony room of the Central Animal Laboratory (Hannover Medical School) under pathogen-free conditions under a 12-h light, 12-h dark cycle at 24°C with food and tap water available ad libitum. Only male offspring were used for the present study. Animals were microbiologically monitored according to Federation of European Laboratory Animal Science Association recommendations (11). All research and animal care procedures were approved by the Government of Lower Saxony (Hannover, Germany), and performed in compliance with international animal welfare standards.
Presently, Brown Norway (BN) rats represent the rat strain preferentially used in research using models of experimental asthma. However, because it has been documented that BN rats—depending on the provider—can show granulomatous pneumonia spontaneously, this may greatly modify their predisposition for asthma. Because, furthermore, the recruitment of T cells to the lungs depends on the expression of CD26, F344 rats represent a highly relevant rat strain, in particular because CD26-deficient substrains are available (10, 12). In addition, the F344 strain might be a relevant alternative as their asthmoid-like response has recently been characterized in detail (13), demonstrating hyperreactive airways compared with other strains and exhibiting greater contractile responses along with greater density of airway smooth muscles compared with Lewis rats (10). An important mechanism mediating the effects of postnatal experiences on behavioral and physiological responses in adult rats is found in persistent changes of the hypothalamic-pituitary-adrenal (HPA) axis (4, 5, 14), which exhibits genetically determined differences between rat strains and which is highly responsive in F344 rats in contrast to Lewis rats (6, 15).
Experiments and postnatal manipulations
In experiment 1, we randomly allocated newborn male Fischer F344 rats (n = 26) derived from 18 litters to the different experimental conditions (MS, n = 9, six litters; HA, n = 10, six litters) as well as to the control group (CO, n = 7, six litters). These animals were used to characterize behavioral differences at the age of 3–4 mo and susceptibility to experimental asthma in the age of 5 mo. Experiment 2 was conducted in male F344 rats (n = 23) kept and reared at identical conditions. These animals were derived from 14 litters (MS, n = 8, five litters; HA, n = 8, five litters: CO, n = 7, four litters). In these animals we screened blood, thymus, and spleen by immunohistology and FACS analysis at the age of 5 mo and also performed assays on blood T cell proliferation and ex vivo splenic NK cell cytotoxicity to study whether these early life experiences primarily affect the immune system of the rats.
During the MS procedure, a dam was placed into a separate cage for 2 h every day, while the pups remained in the nest on their own. This procedure serves as a paradigm for adverse early life experience comprising repeated MS/deprivation (16). In the HA group, each pup, one by one, was placed into a separate cage filled with standard bedding for 5 min every day until being reunited with their mothers. This procedure is regarded as a paradigm for beneficial stimulation early in life comprising repeated exposure to novelty, tactile, and kinesthetic stimulation of pups (16). MS and HA procedures were performed once daily until weaning on postnatal day 28. In CO, dams and their litters were left undisturbed. All procedures were conducted by the same examiner and at the same time of day.
Behavioral tests of emotionality and anxiety
At the age of 3–4 mo, we subjected the animals from experimental set 1 to a test battery for activity, anxiety, and exploratory-like differences, using established assays (16). Here, only the social interaction (SI) test is described in further detail, because the other behavioral tests revealed consistent results. In the SI test, a single experimental rat was exposed to another individual from the same experimental group (e.g., both rats from HA) but from another home cage to provide an intense social stimulus (16, 17). Tests were separated over several days to avoid cohort removal effects in cages with three animals (17). SI testing was conducted in the light phase of the 24-h cycle using a specially designed 50- x 50- x 40-cm box. The observation period was 10 min. The dependent variable was the time spent in SI such as sniffing, following, crawling, and grooming the partner measured by a stopwatch and counted for pairs of rats as previously described (17, 18). Under these conditions, an increase of SI time is interpreted as an anxiolytic-like response and vice versa.
Sensitization and allergen challenge in the asthma disease model
At 5 mo, the animals (experiment 1) were immunized with OVA in a time frame of 2 wk and consecutively challenged by intratracheal (i.t.) instillation of the same Ag according to (10). In brief, sensitization was performed with 1 mg of OVA (Sigma-Aldrich) and 200 mg of Al(OH)3 (Sigma-Aldrich) in 1 ml 0.9% (sterile, pyrogen-free) NaCl applied s.c. As second adjuvant, concentrated preparations of 5 x 109 heat-killed Bordetella pertussis (donated by the manufacturers, Chiron Behring) in 0.4 ml of 0.9% NaCl were given i.p. at the same time. These injections were repeated 7 days after the first sensitization. After another 7 days, the animals were challenged with 300 µl of a 0.5% OVA/saline solution. For this i.t. instillation, a short combined isoflurane oxygen inhalation anesthesia was performed, and the rats were suspended in a hanging position by a rubber band fixed to the incisor teeth of the upper jaw (19). The trachea was intubated via the oral cavity, and the lungs were blown up with air before OVA instillation to check the correct position of the tube.
Dissection of animals, and isolation of bronchoalveolar lavage (BAL) and lung tissue leukocytes
The animals were dissected under isoflurane anesthesia 22 ± 2 h after i.t. challenge as described by Kruschinski et al. (10). Briefly, the abdominal wall was opened and the animals were euthanized by aortic exsanguination. A cannula was inserted into the trachea in situ and the lungs were lavaged with portions of 5 ml of cold (4°C) NaCl. The fluid was retrieved by gentle aspiration and this procedure was repeated 10 times. The recovery of fluid was over 90% in all animals. The BAL was pooled, centrifuged (400 x g, 10 min), and the cell pellet was resuspended in 1 ml of PBS (Seromed; containing 1% BSA (Merck) and 0.1% sodium azide (NaN3; Sigma-Aldrich). For lung cell extraction, a mechanical disaggregation method was used. The trachea, main bronchi, and hilar lymph nodes were removed from the rest of the lung tissue, and the left lung was used for cellular analysis. The complete lung tissue was disaggregated by passing it through a metal sieve with two rounded tweezers and rinsing with 40 ml of PBS. Cells were separated from debris by passing through a 75-µm nylon mesh and centrifuged (400 x g, 10 min). The cell pellet was finally resuspended in 1 ml of PBS. The right lower lobe was kept at –80°C until use for PCR.
Cell counts, stainings for eosinophils, and FACS analysis
Leukocyte numbers were determined via staining with Türks solution (Merck) in a Neubauer counting chamber. The eosinophil cell count was assessed on slides prepared by centrifuging 1 x 105 cells in anticoagulant (100 ml of 0.9% NaCl; 100 mg EDTA; 5 g of BSA; pH 7.2) for 8 min at 800 x g in a cytospin centrifuge (Shandon). After a Pappenheim (combined May-Grünwald/Giemsa) staining (Riedel de Haen), eosinophils were identified under the light microscope at x 1000 magnification. At least 1000 cells were differentiated on each slide.
For FACS analysis, cells were transferred to a microtiter plate (Greiner; with
1 x 106 cells in each well) and washed twice with 100 µl of PBS, also including incubation with 50 µl of human serum (1:10) for 5 min (as described in Ref. 19). For details of the specificity and characteristics of the Abs used, see Ref. 20 . A PE-conjugated secondary anti-mouse Ab was used (
PE; Dianova) to detect the primary Abs: mAb Ox61, mAb Ox8, mAb ED1, and mAb RP1. For double and triple stainings, additional mouse anti-rat FITC-conjugated primary mAbs (mAb R73, mAb Ox12, mAb 10/78), and biotinylated Abs (mAb Ox39, mAb W3/25) were used (all Serotec). These Abs were traced with streptavidin Red 670 (Invitrogen Life Technologies). All incubations were done for 30 min at 4°C in 50-µl portions with alternating washing procedures. Finally, the cells were washed three times, resuspended in 200 µl of PBS, and analyzed on a FACScan flow cytometer (BD Biosciences) focusing on the mononuclear cell gate. At least 20,000 events were counted in the previously defined cell gate, and the percentage was calculated for each cell subset.
Adrenocorticotropin (ACTH)-, cytokine-, and IgE-ELISA
Blood plasma was obtained at two different time points. At the age of 4 mo (before OVA sensitization), the rats were put under short isoflurane anesthesia for puncture of the retro-orbital sinuses. The second blood specimen was taken from the abdominal aorta at the time point of exsanguination after OVA challenge. EDTA-plasma samples were kept at –80°C until use. ACTH, IL-4, IL-6, IL-10, IL-13, and IgE were measured by means of ELISA using previously described standard techniques for hormones and cytokines according to Straub et al. (21) and for IgE according to Kruschinski et al. (10). These parameters were selected as they represent a rational based cross-section for screening on differences in allergic-like and stress-like responses (10, 13, 16).
Semiquantitative RT-PCR
Total RNA from rat lungs was isolated with TriFast-Reagent (peqLAB) and 3 µg of RNA was reverse transcribed using Superscript reverse transcriptase (Invitrogen Life Technologies), random primers and deoxynucleoside triphosphates. The reverse transcriptase products were amplified with TaqDNA polymerase (Invitrogen Life Technologies). PCR was performed for IL-1β (34 cycles, forward primer: 5'-TGT CAC TCA TTG TGG CTG TG-3', reverse primer: 5'-CTG ATG TAC CAG TTG GGG AAC-3', 526 bp), for IL-6 (30 cycles, forward primer: 5'-TGT TGT TGA CAG CCA CTG GC-3', reverse primer: 5'-TTT CAA GAT GAG TTG GAT GGT C-3', 533 bp), for IL-10 (33 cycles, forward primer: 5'-GCT CAG CAC TGC TAT GTT GCC TG-3', reverse primer: 5'-CAC CTG CTC CAC TGC CTT GC-3', 419 bp), for IL-13 (34 cycles, forward primer: 5'-ATG GCA CTC TGG GTG ACT G-3', reverse primer: 5'-GGC CAT TCA ATA TCC TCT GG-3', 277 bp), for TNF-
(32 cycles, forward primer: 5'-TCC AGT GAC AAG CCT GTA GC-3', reverse primer: 5'-TGG TCC CCC TTC TCC AG-3', 368 bp), and normalized to the expression of 18S-rRNA (19 cycles, forward primer: 5'-CCT GCG GCT TAA TTT GAC TC-3', reverse primer: 5'-GGC CTC ACT AAA CCA TCC AA-3', 510 bp). All oligonucleotides were obtained from MWG-Biotech. PCR products were separated by 1% agarose gel electrophoresis and quantified densitometrically using a Gel Doc image analysis system (Bio-Rad).
FACS analysis and immunohistochemistry of leukocyte subpopulations in blood, thymus, and spleens
In experiment 2, analysis of leukocyte subpopulations in blood, thymus, and spleens by FACS analysis was conducted as described above (19). In addition, immunohistochemistry was performed using mAbs characterizing NK cells (mAb 3.2.3), CD4+ T cells (mAbs R73+W3/25+), and CD8+ T cells (mAbs R73+OX8+), B lymphocytes (mAbs HIS14 or OX33), monocytes (mAb ED1), and granulocytes (mAb RP1). The characterization of these mAbs has previously been summarized (20). For immunohistochemistry, two consecutive alkaline phosphatase antialkaline phosphatase stainings were performed as previously described (22, 23). Immunohistochemistry was used in addition to FACS because this approach provides insights into morphology of organs and local distribution of leukocyte subsets.
NK cell cytotoxicity in splenocytes and blood T cell proliferation assay
In experiment 2, NK cytotoxicity was measured in classical 51Cr-release assays using splenocytes and MADB106 target cells (12, 24), which were derived from standard cell culture conditions, as previously described (23). Leukocyte numbers were determined using a Coulter cell counter and the splenocyte concentrations adjusted to 6 x 106 cells/ml with supplemented RPMI 1640 containing 10% FBS. Splenocytes, prepared through Ficoll-Hypaque gradient, were used as effectors and E:T ratios of 12.5:1, 25:1, 50:1, 100:1 were obtained. Coincubation of effector and target cells was conducted either for 4 h with addition of 1000 U/ml IL-2 (EuroCetus) or for 18 h of incubation, respectively. Control wells containing only labeled targets were also plated to determine the spontaneous release. For determination of maximal possible release, the targets in one set of control wells were lyzed with Triton X-100. The spontaneous release was always <10% of the maximum release. Plates were centrifuged for 4 min before incubation (37°C, 5% CO2) and again before harvesting 75 µl of the supernatant for determining 51Cr release in a gamma counter. The specific cytotoxicity was calculated by means of the following formula: ((experimental release – spontaneous release)/(maximal release – spontaneous release)) x 100.
For determination of lymphocyte proliferation, PBMC were isolated from blood via centrifugation on Ficoll gradient (Ficoll Paque Plus; Amersham). Viable cells were counted, washed, and the proliferation assays were conducted in 96-well flat-bottom plates using 2 x 105 cells/well were cultured in the presence of 0.2 µg of
β TCR Ab (plate bound). Cells stimulated with 1 µg of Con A served as positive controls. After 5 days of incubation, the proliferation rate was quantified by BrdU incorporation and detected with a specific colorimetric BrdU cell proliferation ELISA (Roche Molecular Biochemicals), according to the manufacturers instructions. BrdU incorporation was measured using an ELISA reader (PowerWaveXS Universal Microplate Spectrophotometer; BioTek Instruments) at 370 and 492 nm as reference wavelengths. Results were expressed as absorbance rates (A370 nm–A492 nm).
Statistics
Statistical analysis was performed using one-way ANOVA with the factor "experience (CO, MS, or HA)" followed by the Fisher-protected least-significant difference test for post-hoc comparison, if appropriate. For the neuroendocrine data and NK cell-mediated-specific cytotoxicity, a two-way ANOVA for repeated measurements was applied. In the figures, asterisks and number signs are used to indicate a statistically significant difference derived from corresponding post-hoc comparisons vs CO (p values: *, <0.05; **, <0.01; and ***, <0.001) or between MS and HA conditions (p values: #, <0.05; ##, <0.01; or ###, < 0.001). All data are given as arithmetic mean ± SEM.
| Results |
|---|
|
|
|---|
In the SI test of anxiety, HA rats showed increased time spent in SI compared with CO and MS (p < 0.0001; Fig. 1A). Furthermore, rats of the MS group showed significantly less time spent in SI compared with CO.
|
The percentage of eosinophils in the BAL was significantly higher in MS compared with HA (p = 0.03; Fig. 2B). Absolute eosinophil numbers showed significantly higher cell counts in MS animals compared with both the CO and the HA group (p = 0.002; Fig. 2C). Overall, HA animals showed the lowest level of eosinophil cell counts of all three groups. No other differences were found in leukocytes subsets of the BAL (data not shown).
|
The finding of an allergen-induced eosinophilia in the bronchoalveolar space was verified in the lung via FACS analysis resulting in the same distribution pattern of highest levels in MS animals in all T cell-relevant surface markers. Here, as an example of significant effects, the T cell subtypes CD25+ (p < 0.05; Fig. 3A), CD8+ (p < 0.05; Fig. 3B), and CD25+CD26+ (p = 0.04; Fig. 3C) are shown.
|
IL-13 levels in the blood plasma significantly increased 22 h after OVA challenge in HA compared with CO (p < 0.05; Fig. 4A). For IL-10, no differences were found (data not shown). IL-6 pre- and postchallenge levels (Fig. 4B) exhibited a decrease over the clinical course (p < 0.001): a significant reduction of 26% was seen in CO, and also in MS a 22% reduction was demonstrated. No significant reduction was found in HA. IL-4 levels were not detectable in any of the animals investigated (data not shown), which is consistent with the literature at that early time point (25). Similar to IL-13, significantly higher IgE levels in HA compared with MS were found 22 h after OVA challenge (p = 0.03; Fig. 4C).
|
Cytokine mRNAs measured in the lung parenchyma showed significant differences only for IL-1β. IL-1β concentrations were significantly reduced in HA compared with both the CO and the MS group (p = 0.01) (Fig. 5A). The other cytokines studied (IL-6, IL-10, IL-13, TNF-
, and IFN-
), did not reveal significant results between the different experimental groups. However, transcript levels of IL-6, similar to IL-6 measured in the blood plasma, failed to show a significant increase in HA (Fig. 5B).
|
ANOVA for repeated measurements revealed a significant interaction of both factors (p = 0.002), indicating both a "treatment" and a "time" specific effect. At baseline, HA rats showed significantly lowest ACTH levels compared with MS (one-way ANOVA; p = 0.04; Fig. 6A) as well as lower levels than CO rats. Comparing pre- to postchallenge, in HA ACTH levels were most impressively increased. Also in CO, ACTH levels were significantly increased, whereas in MS the increase was not significant. As a result, after OVA challenge, ACTH levels were significantly higher in HA compared with CO as well as MS (one-way ANOVA, p = 0.02).
|
To investigate whether these early life experiences primarily affect the immune system of the rats, we screened blood, thymus, and spleen by immunohistology and FACS analysis and also measured blood T cell proliferation and ex vivo NK cell cytotoxicity in a separate set of animals that were otherwise experimentally naive (i.e., no behavioral assays, immunization, and OVA challenge; experiment 2). We found no differences in immunohistology or composition of leukocyte subsets after screening blood, spleen, and thymus of CO, MS, and HA animals (data not shown). Also, T cell proliferation did not differ among groups (data not shown). Only ex vivo NK cytotoxicity differed between groups with significantly higher NK cytotoxicity in the HA group. NK-specific lysis of MADB106 tumor cells using a classical ex vivo NK cell functional assay is shown in Fig. 6, B and C. Two-way ANOVA showed a significant effect of the factors "postnatal experience" (p < 0.001) and "E:T ratio" (p < 0.05) in the 4-h (Fig. 6B) and the 18-h (Fig. 6C) assays. Post-hoc analyses revealed in both assays that in the CO and MS animals, NK cell-mediated lysis against MADB106 tumor targets was significantly lower compared with HA rats.
| Discussion |
|---|
|
|
|---|
|
Also in the present study, HA animals exhibit lowest, CO intermediate, and MS highest basal ACTH levels. Following Ag challenge, however, ACTH concentrations were significantly higher in HA, indicating the most intensive activation of the HPA axis. This evidence for a more dynamic responsiveness of the HPA axis could also explain why the inflammatory responses to the allergic airway disease are more tightly controlled in HA. IL-6 is one candidate mediator, which might serve as an immune-to-brain "stress" signal also in the present experiments (Fig. 7). IL-6 is known to be a potent activator of the HPA system and is secreted under stress conditions (29). The IL-6 release from macrophages is furthermore under tight control of the activity of the sympathetic nervous system and related neurotransmitters, which in turn are released by stress (30). However, because IL-6 levels do not differ prechallenge between groups and show under poststress circumstances only a significant decrease in MS and CO groups, these findings are not indicative for an activation of the HPA system by IL-6 but instead may hint to additional differences in the sympathetic response (30) in these animals.
It is a widely accepted hypothesis that severe postnatal or acute experiences of stress can induce a persistent state of hyporesponsiveness of the HPA axis. Similarly, some populations with posttraumatic stress disorder show lower mean basal cortisol levels throughout the circadian cycle (31). Furthermore, a state of stress-induced HPA hyporesponsiveness in some research subjects has been associated with other inflammatory disorders such as atopic dermatitis (32). Similarly, we found no differences between pre- and posttreatment ACTH levels in the MS group, which might indicate a hyporesponsive HPA axis ultimately leading to exacerbations of asthma in MS individuals that underwent repeated postnatal "chronic" stress with a potentially long-lasting and persisting impact on the immune regulatory competence of the individual (Fig. 7).
To study whether these early life experiences primarily affect the immune system of the rats, which then would not develop an appropriate inflammatory response following challenge with OVA, we have performed an additional experiment using an identical experimental design but omitting behavioral testing as well as immunization and induction of asthma. Screening of blood, thymus, and spleen by immunohistology and FACS analysis as well as T cell proliferation revealed no differences among groups. Only testing ex vivo splenic NK cytotoxicity revealed significantly higher NK cytotoxicity in HA animals. As this finding might well be the result of a differential in vivo stress response mediated via sympathetic neurotransmitters such as noradrenaline and neuropeptide Y (12, 16, 20, 22, 23, 24, 30), to this end, we conclude that the postnatal stressors used in the present study do not primarily affect the immune system of the rats. However, such a conclusion cannot be comprehensive and might differ in the case of other postnatal experiences such as immune "stress" by early postnatal exposure to endotoxin (5, 7, 16). Also, other components of the immune system, which were not studied here, may potentially be affected by postnatal experiences. In terms of the postnatal development of immune regulation, prospective seroepidemiological studies showed that the newborn period is dominated by Th2 reactivity in response to allergens (31). It is also evident that the Th1 memory cells selectively develop shortly after birth (at 3–6 mo of age) and persist into adulthood in nonatopic subjects. For most children who become allergic or asthmatic, the polarization of their immune system into an atopic phenotype probably occurs during early childhood (33). A contributing factor for such a Th1-Th2 shift might be provided by the postnatal environment as exemplified in the present study. Furthermore, in the present study, HA animals were characterized by lower numbers of T cell subtypes such as CD25+CD26+ T cells. CD25 and CD26 are both known as activation markers of T cells (9, 34, 35). In recent studies, we were able to show that CD26-negative rat strains (12) exhibited a significant reduction of T cell numbers in the BAL compared with CD26-positive wild-type controls (10) and that a dose-dependent recruitment of activated CD4+CD25+CD26+Foxp3– T cell subpopulations is evident, which has not yet been described in asthma (13). Therefore, the present study illustrates an association of different postnatal stressor, CD26 expression, and T cell activation.
Interestingly, in the present results, IgE as well as IL-13 levels showed an inverse proportion relative to eosinophils and other leukocyte subsets. IgE concentrations were highest in HA animals that showed the least leukocyte subset changes in the lungs. As shown for ACTH-levels, HA animals exhibited a remarkable ability of quick regulation and control mechanisms, e.g., to contain overwhelming immunoreactions against pathogens that might harm the organism (36). In a study by von Hörsten et al. (37), splenic B cell responses to classical Ags such as sheep RBC were increased in adult postnatally HA rats, whereas postnatal MS suppressed this response in adult individuals. These findings are consistent with the elevated IgE level of the HA animals in the present study and are not necessarily contradictory to a reduced eosinophilia, because Ab production and other components of an allergic immune response might be regulated more or less independently (38).
In conclusion, we provide direct experimental evidence in rats illustrating that susceptibility to asthma is influenced—apart from genetic and recently considered hygienic factors—by the postnatal psychosocial environment. Postnatal stressors representing paradigms of either beneficial or adverse life experience either protect or aggravate the course of experimental asthma in adult animals and are associated with persistent changes in the behavioral and neuroendocrine stress responsiveness as well as recruitment of the activated T cells. These findings will motivate interdisciplinary research on specific factors acting at the neuroendocrinoimmune interface and exerting persistent modulatory effects on the adaptiveness of the individual to allergic challenge.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft), SFB587, Project B11. ![]()
2 Address correspondence and reprint requests to Dr. Stephan von Hörsten, Experimental Therapy, Franz-Pentzoldt Center, Friedrich-Alexander University, 91054 Erlangen, Germany. E-mail address: stephan.v.hoersten{at}ze.uni-erlangen.de ![]()
3 Abbreviations used in this paper: MS, maternal stimulation; HA, handling stimulation; CO, control; HPA, hypothalamic-pituitary-adrenal; SI, social interaction; i.t., intratracheal; ACTH, adrenocorticotropin; BAL, bronchoalveolar lavage. ![]()
Received for publication December 12, 2006. Accepted for publication January 16, 2008.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. A. Shirtcliff, C. L. Coe, and S. D. Pollak Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1 PNAS, February 24, 2009; 106(8): 2963 - 2967. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |